Multiple sclerosis (first of two parts).

McFarlin DE, McFarland HF

N Engl J Med, (19):1183-1188 1982

MED: 6750404

T cells in multiple sclerosis and inflammatory central nervous system diseases.

Hafler DA, Weiner HL

Immunol Rev, 307-332 1987

MED: 3326824

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Milligan NM, Newcombe R, Compston DA

J Neurol Neurosurg Psychiatry, (5):511-516 1987

MED: 3295122

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL

N Engl J Med, (4):173-180 1983

MED: 6294517

Title not supplied

The

Ann Neurol 1990

Title not supplied

The

Neurology 1993

Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.

Pettinelli CB, McFarlin DE

J Immunol, (4):1420-1423 1981

MED: 6168690

Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis with a subset of T lymphocytes.

Holda JH, Swanborg RH

Eur J Immunol, (5):453-455 1982

MED: 6980130

Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.

Brostoff SW, Mason DW

J Immunol, (4):1938-1942 1984

MED: 6236260

Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker.

Waldor MK, Sriram S, Hardy R, Herzenberg LA, Herzenberg LA, Lanier L, Lim M, Steinman L

Science, (4685):415-417 1985

MED: 3155574